These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
192 related articles for article (PubMed ID: 17723153)
1. Usefulness of C-reactive protein in monitoring the severe community-acquired pneumonia clinical course. Coelho L; Póvoa P; Almeida E; Fernandes A; Mealha R; Moreira P; Sabino H Crit Care; 2007; 11(4):R92. PubMed ID: 17723153 [TBL] [Abstract][Full Text] [Related]
2. C-reactive protein as a marker of ventilator-associated pneumonia resolution: a pilot study. Póvoa P; Coelho L; Almeida E; Fernandes A; Mealha R; Moreira P; Sabino H Eur Respir J; 2005 May; 25(5):804-12. PubMed ID: 15863636 [TBL] [Abstract][Full Text] [Related]
3. Usefulness of consecutive C-reactive protein measurements in follow-up of severe community-acquired pneumonia. Bruns AH; Oosterheert JJ; Hak E; Hoepelman AI Eur Respir J; 2008 Sep; 32(3):726-32. PubMed ID: 18508833 [TBL] [Abstract][Full Text] [Related]
4. C-reactive protein correlates with bacterial load and appropriate antibiotic therapy in suspected ventilator-associated pneumonia. Lisboa T; Seligman R; Diaz E; Rodriguez A; Teixeira PJ; Rello J Crit Care Med; 2008 Jan; 36(1):166-71. PubMed ID: 18007271 [TBL] [Abstract][Full Text] [Related]
5. Patterns of c-reactive protein RATIO response in severe community-acquired pneumonia: a cohort study. Coelho LM; Salluh JI; Soares M; Bozza FA; Verdeal JC; Castro-Faria-Neto HC; Lapa e Silva JR; Bozza PT; Póvoa P Crit Care; 2012 Dec; 16(2):R53. PubMed ID: 22449513 [TBL] [Abstract][Full Text] [Related]
6. Performance of a bedside C-reactive protein test in the diagnosis of community-acquired pneumonia in adults with acute cough. Flanders SA; Stein J; Shochat G; Sellers K; Holland M; Maselli J; Drew WL; Reingold AL; Gonzales R Am J Med; 2004 Apr; 116(8):529-35. PubMed ID: 15063814 [TBL] [Abstract][Full Text] [Related]
7. Impact of serum C-reactive protein measurements in the first 2 days on the 30-day mortality in hospitalized patients with severe community-acquired pneumonia: a cohort study. Nseir W; Farah R; Mograbi J; Makhoul N J Crit Care; 2013 Jun; 28(3):291-5. PubMed ID: 23159134 [TBL] [Abstract][Full Text] [Related]
8. C-reactive protein for discriminating treatment failure from slow responding pneumonia. Ruiz-González A; Falguera M; Porcel JM; Martínez-Alonso M; Cabezas P; Geijo P; Boixeda R; Dueñas C; Armengou A; Capdevila JA; Serrano R Eur J Intern Med; 2010 Dec; 21(6):548-52. PubMed ID: 21111942 [TBL] [Abstract][Full Text] [Related]
9. C-reactive protein is an independent predictor of severity in community-acquired pneumonia. Chalmers JD; Singanayagam A; Hill AT Am J Med; 2008 Mar; 121(3):219-25. PubMed ID: 18328306 [TBL] [Abstract][Full Text] [Related]
10. Hepatocyte growth factor is a better indicator of therapeutic response than C-reactive protein within the first day of treatment in pneumonia. Abednazari H; Xu J; Millinger E; Brudin L; Forsberg P; Nayeri F Chemotherapy; 2006; 52(5):260-3. PubMed ID: 16899975 [TBL] [Abstract][Full Text] [Related]
11. Pilot study evaluating C-reactive protein levels in the assessment of response to treatment of severe bloodstream infection. Póvoa P; Coelho L; Almeida E; Fernandes A; Mealha R; Moreira P; Sabino H Clin Infect Dis; 2005 Jun; 40(12):1855-7. PubMed ID: 15909277 [TBL] [Abstract][Full Text] [Related]
12. Efficacy of methylprednisolone in children with severe community acquired pneumonia. Nagy B; Gaspar I; Papp A; Bene Z; Nagy B; Voko Z; Balla G Pediatr Pulmonol; 2013 Feb; 48(2):168-75. PubMed ID: 22588852 [TBL] [Abstract][Full Text] [Related]
13. Albumin and C-reactive protein have prognostic significance in patients with community-acquired pneumonia. Lee JH; Kim J; Kim K; Jo YH; Rhee J; Kim TY; Na SH; Hwang SS J Crit Care; 2011 Jun; 26(3):287-94. PubMed ID: 21129911 [TBL] [Abstract][Full Text] [Related]
14. C-reactive protein, severity of pneumonia and mortality in elderly, hospitalised patients with community-acquired pneumonia. Thiem U; Niklaus D; Sehlhoff B; Stückle C; Heppner HJ; Endres HG; Pientka L Age Ageing; 2009 Nov; 38(6):693-7. PubMed ID: 19729453 [TBL] [Abstract][Full Text] [Related]
15. Changes in serum cortisol levels during community-acquired pneumonia: the influence of dexamethasone. Remmelts HH; Meijvis SC; Kovaleva A; Biesma DH; Rijkers GT; Heijligenberg R Respir Med; 2012 Jun; 106(6):905-8. PubMed ID: 22402329 [TBL] [Abstract][Full Text] [Related]
17. Pro-adrenomedullin to predict severity and outcome in community-acquired pneumonia [ISRCTN04176397]. Christ-Crain M; Morgenthaler NG; Stolz D; Müller C; Bingisser R; Harbarth S; Tamm M; Struck J; Bergmann A; Müller B Crit Care; 2006; 10(3):R96. PubMed ID: 16805922 [TBL] [Abstract][Full Text] [Related]
18. Serum hydrogen sulfide as a novel marker predicting bacterial involvement in patients with community-acquired lower respiratory tract infections. Chen YH; Yao WZ; Gao JZ; Geng B; Wang PP; Tang CS Respirology; 2009 Jul; 14(5):746-52. PubMed ID: 19659653 [TBL] [Abstract][Full Text] [Related]
19. Role of C-reactive protein in response-guided therapy of pyogenic liver abscess. Law ST; Li KK Eur J Gastroenterol Hepatol; 2014 Feb; 26(2):179-86. PubMed ID: 24025976 [TBL] [Abstract][Full Text] [Related]